TARA Protara Therapeutics, Inc. - Common Stock
$4,08
Harga · Agu 19, 2026
Fundamental per Agu 11, 2026
Rentang 52M
$3–$8
23% of range
Peringkat Analis
BUY
14 analysts
Target Harga
$26
+531% upside
P/E (TTM)
-3.0
ROE
-33.7%
Margin Laba Bersih
—
Tentang Protara Therapeutics, Inc. - Common Stock Tinjauan perusahaan dari Wikipedia
Proteon Therapeutics, Inc. is a developer of pharmaceuticals with offices in Waltham, Massachusetts and Kansas City, Missouri.
Baca selengkapnya
Proteon Therapeutics, Inc. is a developer of pharmaceuticals with offices in Waltham, Massachusetts and Kansas City, Missouri.
Company History
Proteon was founded by Dr. F. Nicholas Franano based on technology created at Johns Hopkins University. Major investors in the company include MPM Capital, Rockhill Partners, TVM Capital, Skyline Ventures, Prism VentureWorks, Vectis Life Sciences and Intersouth Partners. They have invested over $72 million in the company.
The company is led by Timothy Noyes, CEO; Steven Burke, CMO; George Eldridge, CFO; and Scott Toner, director of marketing.
On March 5, 2009, the company announced that it had raised $32 million from its existing investors plus MPM Capital and Vectis Life Sciences. Proteon also announced that it had entered into an option agreement to be acquired by Novartis for up to $550 million. The company went public in 2014.
In September 2019, Proteon Therapeutics merged with ArTara Therapeutics.
PRT-201
Proteon is developing PRT-201 (vonapanitase), a drug to improve blood flow following vascular surgery procedures, and, more broadly, is interested in vascular access for hemodialysis and peripheral arterial disease (PAD). PRT-201 is a recombinant human elastase manufactured for Proteon by Lonza.
In September 2008, the company announced that the Food and Drug Administration had granted fast track status to PRT-201.
In December 2016, they announced that the phase III trial of PRT-201 hadn't reached its primary endpoint, causing Proteon's stock price to drop more than 75%.
Sumber: Wikipedia (English), CC BY-SA 4.0 · Lihat di Wikipedia ↗
TARA Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$4.08
Kapitalisasi Pasar
$218M
P/E (TTM)
-3.0
EPS (TTM)
$-1.34
Pendapatan (TTM)
—
Imbal Hasil Dividen
—
ROE
-33.7%
D/E Utang/Ekuitas
—
Rentang 52M
$3 – $8
TARA Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
Configure
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan & Laba Bersih
—
EPS
$-1.34
2021-12-31
→
2025-12-31
Arus Kas Bebas
$-56M
2016-12-31
→
2025-12-31
Margin
—
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
Metrik
Tren 5 Tahun
TARA
Median Rekan
P/E (TTM)
-3.0
88.5
P/B
1.1
3.6
Price / FCF (Harga / FCF)
-3.9
—
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
Metrik
Tren 5 Tahun
TARA
Median Rekan
ROA
-29.4%
-38.8%
ROE
-33.7%
-61.0%
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
Metrik
Tren 5 Tahun
TARA
Median Rekan
Current Ratio (Rasio Lancar)
14.6
3.9
Quick Ratio (Rasio Cepat)
14.2
—
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Metrik
Tren 5 Tahun
TARA
Median Rekan
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
Metrik
Tren 5 Tahun
TARA
Median Rekan
TARA Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
BELI
14 analis
- Beli Kuat 3 21,4%
- Beli 10 71,4%
- Tahan 1 7,1%
- Jual 0 0,0%
- Jual Kuat 0 0,0%
Target Harga 12 Bulan
7 analis · 2026-08-20
Median
$26.00
← Di bawah semua target
$4.08
Rendah
$20.00
Tinggi
$30.00
Target median
$26.00
+538,0%
Target rata-rata
$25.71
+531,0%
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
0.07%
| Periode | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|
| 31 Maret 2026 | $-0.31 | $-0.38 | 0.07% |
| 31 Des. 2025 | $-0.37 | $-0.33 | -0.04% |
| 30 Sep. 2025 | $-0.31 | $-0.39 | 0.08% |
| 30 Juni 2025 | $-0.35 | $-0.41 | 0.06% |
| 31 Maret 2025 | $-0.29 | $-0.46 | 0.17% |
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| TARA | $286M | -4.0 | — | — | -33.7% | — |
| GLSI | $300M | -14.7 | — | — | -2159.7% | — |
| EBS | $644M | 13.3 | -28.8% | 7.1% | 9.9% | — |
| ORGO | $658M | 34.5 | 17.0% | 6.6% | 13.9% | — |
| AKBA | $427M | -80.5 | 47.5% | -2.3% | -17.3% | — |
| DTIL | $100M | -1.2 | -50.1% | -133.4% | -72.4% | — |
| NERV | $174M | -0.1 | — | — | 339.5% | — |
| RNA | $10.91B | -14.5 | 72.1% | -3650.4% | -47.5% | — |
| CNXU | — | — | — | — | — | — |
| IMUX | — | -0.9 | — | — | — | — |
| TNXP | $200M | -1.1 | 29.8% | -946.2% | -60.0% | — |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi 16
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | · | · | · | · | $3M | |
| R&D Expense | $43M | $32M | $25M | $17M | $21M | $12M | $4M | $12M | $22M | $19M | $12M | $6M | |
| SG&A Expense | $22M | $17M | $19M | $21M | $26M | $22M | $4M | $10M | $9M | $10M | $8M | $4M | |
| Operating Expenses | $65M | $49M | $44M | $67M | $47M | $34M | $8M | $21M | $30M | $29M | $21M | $11M | |
| Operating Income | $-65M | $-49M | $-44M | $-67M | $-47M | $-34M | $-8M | $-21M | $-30M | $-29M | $-21M | $-8M | |
| Interest Expense | · | · | · | · | $0 | $34.0K | · | · | · | · | · | $857.0K | |
| Interest Income | $6M | $4M | $3M | $1M | $237.0K | $500.0K | · | · | · | · | · | · | |
| Other Non-op | $7M | $5M | $3M | $1M | $237.0K | $466.0K | · | $207.0K | $139.0K | $-14.0K | $-651.0K | $5M | |
| Pretax Income | $57M | $45M | · | · | · | · | $-15M | $-21M | $-30M | $-29M | $-21M | $-3M | |
| Income Tax | · | · | · | · | · | · | · | · | · | · | · | $-110.0K | |
| Net Income | $-57M | $-45M | $-40M | $-66M | $-47M | $-34M | $-8M | $-21M | $-30M | $-29M | $-21M | $-3M | |
| EPS (Basic) | $-1.34 | $-2.17 | $-3.57 | $-5.86 | $-4.21 | · | · | · | · | · | · | · | |
| EPS (Diluted) | $-1.34 | $-2.17 | $-3.57 | $-5.86 | $-4.21 | · | · | · | · | · | · | · | |
| Shares (Basic) | 42,836,129 | 20,592,847 | 11,331,338 | 11,259,615 | · | · | · | · | · | · | · | · | |
| Shares (Diluted) | 42,836,129 | 20,592,847 | 11,331,338 | 11,259,615 | 11,232,576 | · | · | · | · | · | · | · | |
| EBITDA | $-65M | $-49M | $-44M | $-67M | $-47M | $-34M | $-15M | · | · | $-29M | $-21M | $-8M |
Neraca 23
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $50M | $163M | $40M | $24M | $36M | $169M | $564.0K | $19M | $21M | $36M | $40M | $69M | |
| Short-term Investments | $106M | $7M | $26M | $60M | $56M | · | · | $2M | $21M | $5M | $25M | $15M | |
| Prepaid Expense | $4M | $2M | $3M | $2M | $2M | $787.0K | $78.0K | $1M | $1M | $1M | $1M | $1M | |
| Other Current Assets | $65.0K | $2.0K | $37.0K | $127.0K | $34.0K | $52.0K | · | · | · | · | · | · | |
| Current Assets | $160M | $172M | $69M | $86M | $93M | $169M | $764.0K | $23M | $43M | $43M | $67M | $85M | |
| PP&E (Net) | $759.0K | $1M | $1M | $2M | $2M | $1M | $459.0K | $263.0K | $259.0K | $372.0K | $224.0K | $83.0K | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | $2M | $1M | $475.0K | $1M | $971.0K | $937.0K | $665.0K | $467.0K | |
| Accum. Depreciation | $1M | $1M | $824.0K | $483.0K | $236.0K | $119.0K | $16.0K | $827.0K | $712.0K | $565.0K | $441.0K | $384.0K | |
| Goodwill | · | · | · | · | $30M | $30M | · | · | · | · | · | · | |
| Other Non-current Assets | $20.0K | $27.0K | $11.0K | $16.0K | $865.0K | $1M | · | · | $218.0K | $393.0K | $706.0K | $114.0K | |
| Total Assets | $209M | $181M | $79M | $113M | $173M | $203M | $1M | $24M | $44M | $44M | $68M | $85M | |
| Accounts Payable | $3M | $4M | $2M | $2M | $954.0K | $914.0K | $716.0K | $441.0K | $291.0K | $556.0K | $1M | $917.0K | |
| Accrued Liabilities | $6M | $5M | $3M | $3M | $2M | $2M | $3M | $3M | $9M | $5M | $3M | $1M | |
| Current Liabilities | $11M | $11M | $6M | $6M | $4M | $3M | $3M | $3M | $9M | $5M | $4M | $2M | |
| Capital Leases | $2M | $3M | $4M | $5M | $6M | $999.0K | · | · | · | · | · | · | |
| Total Liabilities | $13M | $14M | $11M | $11M | $11M | $4M | $3M | $3M | $9M | $5M | $4M | $2M | |
| Common Stock | $54.0K | $35.0K | $11.0K | $11.0K | $11.0K | $11.0K | $3.0K | · | $18.0K | $17.0K | $16.0K | $16.0K | |
| Paid-in Capital | $499M | $412M | $269M | $263M | $256M | $246M | $11M | $209M | $203M | $198M | $195M | $192M | |
| Retained Earnings | $-302M | $-245M | $-200M | $-160M | $-94M | $-47M | $-13M | $-210M | $-190M | $-160M | $-131M | $-110M | |
| AOCI | $90.0K | $2.0K | $-31.0K | $-688.0K | $-211.0K | · | $3.0K | $5.0K | $-14.0K | · | $-11.0K | $-6.0K | |
| Stockholders' Equity | $196M | $167M | $68M | $102M | $162M | $199M | $-2M | $5M | $35M | $38M | $63M | $82M | |
| Liabilities + Equity | $209M | $181M | $79M | $113M | $173M | $203M | $1M | $24M | $44M | $44M | $68M | $85M | |
| Shares Outstanding | 53,587,260 | 35,044,772 | 11,364,903 | 11,267,389 | 11,235,731 | 11,211,840 | 2,627,533 | 481,091 | 17,674,729 | 16,603,559 | 16,501,500 | 16,448,455 |
Arus Kas 14
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | · | $123.0K | $57.0K | $30.0K | |
| Stock-based Comp | $4M | $4M | $6M | $7M | $10M | $10M | $424.0K | $3M | $3M | $3M | $2M | $459.0K | |
| Deferred Tax | $-11M | $-20M | $-14M | $-9M | $-5M | $-9M | · | · | · | · | · | · | |
| Restructuring | · | · | · | · | · | · | $3M | · | · | · | · | · | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | $1M | $2M | $-7M | |
| Operating Cash Flow | $-56M | $-36M | $-38M | $-26M | $-35M | $-23M | $-5M | $-23M | $-22M | $-24M | $-18M | $-10M | |
| CapEx | $94.0K | $63.0K | $45.0K | $120.0K | $596.0K | $884.0K | $475.0K | $119.0K | $35.0K | $271.0K | $198.0K | $51.0K | |
| Investing Cash Flow | $-139M | $19M | $53M | $15M | $-98M | $3M | $-475.0K | $18M | $-16M | $20M | $-11M | · | |
| Stock Issued | · | · | · | · | · | $74M | · | · | · | · | · | $62M | |
| Stock Repurchased | · | · | $91.0K | $90.0K | $228.0K | · | · | · | · | · | · | · | |
| Net Stock Activity | · | · | $-91.0K | $-90.0K | $-228.0K | $66M | · | · | · | · | · | $62M | |
| Financing Cash Flow | $83M | $140M | $-91.0K | $-90.0K | $-228.0K | $189M | $500.0K | $3M | $23M | $208.0K | $163.0K | · | |
| Net Change in Cash | · | · | · | · | · | · | $-13M | $-2M | $-15M | $-4M | $-29M | $66M | |
| Free Cash Flow | $-56M | $-36M | $-38M | $-27M | $-35M | $-24M | $-16M | · | · | $-24M | $-18M | $-10M |
Profitabilitas 5
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | -7391.4% | · | · | · | · | · | -257.1% | |
| Net Margin | · | · | · | · | · | -7291.4% | · | · | · | · | · | -113.4% | |
| EBITDA Margin | · | · | · | · | · | -7391.4% | · | · | · | · | · | -256.1% | |
| ROA | -29.4% | -34.2% | -42.0% | -46.1% | -25.1% | -33.2% | -98.3% | · | · | -51.4% | -28.1% | -7.4% | |
| ROE | -33.7% | -35.8% | -55.6% | -54.7% | -28.4% | -17.2% | -449.1% | · | · | -56.0% | -29.3% | 37.0% |
Likuiditas & Solvabilitas 3
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 14.6 | 15.7 | 11.2 | 15.0 | 21.7 | 58.1 | 12.0 | · | · | 8.4 | 16.1 | 36.2 | |
| Quick Ratio | 14.2 | 15.5 | 10.7 | 14.7 | 21.2 | 57.8 | 10.6 | · | · | 8.1 | 15.8 | 35.8 | |
| Interest Coverage | · | · | · | · | · | -1013.1 | · | · | · | · | · | -8.8 |
Efisiensi 1
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | 0.0 | · | · | · | · | · | 0.1 |
Valuasi (TTM) 10
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | · | · | · | · | · | · | $3M | |
| Net Income TTM | $-57M | $-45M | $-40M | $-66M | $-47M | $-34M | $-8M | $-21M | $-30M | $-29M | $-21M | $-3M | |
| Market Cap | $286M | $185M | $21M | $30M | $76M | $271M | $9M | · | · | $1.26B | $10.24B | $6.84B | |
| P/E | -4.0 | -2.4 | -0.5 | -0.5 | -1.6 | · | · | · | · | · | · | · | |
| P/S | · | · | · | · | · | · | · | · | · | · | · | 2321.1 | |
| P/B | 1.5 | 1.1 | 0.3 | 0.3 | 0.5 | 1.4 | 1.4 | · | · | 32.8 | 161.5 | 83.0 | |
| P / Tangible Book | 1.5 | 1.1 | 0.3 | 0.3 | 0.6 | 1.6 | · | · | · | · | · | · | |
| P / Cash Flow | -5.1 | -5.2 | -0.6 | -1.1 | -2.2 | -11.6 | -0.6 | · | · | -53.3 | -582.8 | -684.9 | |
| P / FCF | -5.1 | -5.2 | -0.6 | -1.1 | -2.2 | -11.2 | -0.6 | · | · | -52.7 | -576.3 | -681.5 | |
| Earnings Yield | -25.1% | -41.1% | -190.4% | -218.7% | -62.4% | · | · | · | · | · | · | · |
Laporan Laba Rugi 12
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $17M | $14M | $13M | $10M | $11M | $9M | $9M | $8M | $6M | $8M | $6M | $6M | $7M | $5M | $5M | $3M | |
| SG&A Expense | $6M | $6M | $6M | $5M | $6M | $5M | $5M | $4M | $4M | $4M | $5M | $4M | $5M | $5M | $5M | $5M | |
| Operating Expenses | $23M | $20M | $19M | $15M | $17M | $14M | $14M | $12M | $11M | $12M | $11M | $11M | $12M | $10M | $40M | $8M | |
| Operating Income | $-23M | $-20M | $-19M | $-15M | $-17M | $-14M | $-14M | $-12M | $-11M | $-12M | $-11M | $-11M | $-12M | $-10M | $-40M | $-8M | |
| Interest Income | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $756.0K | $820.0K | $840.0K | $846.0K | $687.0K | $542.0K | $283.0K | |
| Other Non-op | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $756.0K | $820.0K | $840.0K | $846.0K | $687.0K | $542.0K | $283.0K | |
| Net Income | $-22M | $-18M | $-17M | $-13M | $-15M | $-12M | $-13M | $-11M | $-10M | $-11M | $-10M | $-10M | $-11M | $-9M | $-39M | $-8M | |
| EPS (Basic) | $-0.36 | $-0.31 | $-0.39 | $-0.31 | $-0.35 | $-0.29 | $-0.25 | $-0.50 | $-0.45 | $-0.97 | $-0.90 | $-0.87 | $-1.00 | $-0.80 | $-3.46 | $-0.68 | |
| EPS (Diluted) | $-0.36 | $-0.31 | $-0.39 | $-0.31 | $-0.35 | $-0.29 | $-0.25 | $-0.50 | $-0.45 | $-0.97 | $-0.90 | $-0.87 | $-1.00 | $-0.80 | $-3.46 | $-0.68 | |
| Shares (Basic) | 61,006,766 | 57,538,833 | -82,414,767 | 42,272,104 | 42,270,855 | 40,707,937 | -34,391,036 | 22,329,772 | 21,233,163 | 11,420,948 | -22,628,260 | 11,347,887 | 11,307,842 | 11,303,869 | -22,511,202 | 11,265,475 | |
| Shares (Diluted) | 61,006,766 | 57,538,833 | -82,414,767 | 42,272,104 | 42,270,855 | 40,707,937 | -34,391,036 | 22,329,772 | 21,233,163 | 11,420,948 | -22,628,260 | 11,347,887 | 11,307,842 | 11,303,869 | -22,511,202 | 11,265,475 | |
| EBITDA | $-23M | $-20M | · | $-15M | $-17M | $-14M | · | $-12M | $-11M | $-12M | · | $-11M | $-12M | $-10M | · | $-8M |
Neraca 23
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $17M | $15M | $50M | $13M | $31M | $91M | $163M | $52M | $90M | $52M | $40M | $34M | $34M | $21M | $24M | $47M | |
| Short-term Investments | $125M | $121M | $106M | $120M | $91M | $33M | $7M | $30M | · | $3M | $26M | $40M | $46M | $66M | $60M | $49M | |
| Prepaid Expense | $4M | $4M | $4M | $3M | $3M | $2M | $2M | $4M | $3M | $3M | $3M | $4M | $4M | $8M | $2M | $2M | |
| Other Current Assets | $230.0K | $17.0K | $65.0K | $218.0K | $78.0K | $16.0K | $2.0K | $3.0K | $4.0K | $3.0K | $37.0K | $2.0K | $1.0K | $127.0K | $127.0K | · | |
| Current Assets | $146M | $140M | $160M | $136M | $125M | $127M | $172M | $85M | $92M | $58M | $69M | $78M | $84M | $95M | $86M | $99M | |
| PP&E (Net) | $1M | $669.0K | $759.0K | $828.0K | $912.0K | $988.0K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | |
| PP&E (Gross) | · | · | $2M | · | · | · | $2M | · | · | · | $2M | · | · | · | $2M | · | |
| Accum. Depreciation | · | · | $1M | · | · | · | $1M | · | · | · | $824.0K | · | · | · | $483.0K | · | |
| Goodwill | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $30M | |
| Other Non-current Assets | $74.0K | $76.0K | $20.0K | $21.0K | $29.0K | $35.0K | $27.0K | $33.0K | $19.0K | $31.0K | $11.0K | $3M | $3M | $586.0K | $16.0K | $734.0K | |
| Total Assets | $176M | $192M | $209M | $145M | $157M | $169M | $181M | $94M | $102M | $68M | $79M | $88M | $95M | $106M | $113M | $149M | |
| Accounts Payable | $5M | $4M | $3M | $5M | $5M | $2M | $4M | $2M | $1M | $972.0K | $2M | $3M | $2M | $4M | $2M | $456.0K | |
| Accrued Liabilities | $7M | $4M | $6M | $4M | $3M | $4M | $5M | $5M | $3M | $4M | $3M | $3M | $2M | $1M | $3M | $2M | |
| Current Liabilities | $13M | $9M | $11M | $10M | $10M | $7M | $11M | $9M | $6M | $6M | $6M | $7M | $5M | $6M | $6M | $4M | |
| Capital Leases | $1M | $2M | $2M | $2M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | $6M | |
| Total Liabilities | $15M | $11M | $13M | $12M | $13M | $10M | $14M | $12M | $10M | $10M | $11M | $12M | $10M | $12M | $11M | $9M | |
| Common Stock | $59.0K | $55.0K | $54.0K | $39.0K | $39.0K | $39.0K | $35.0K | $21.0K | $21.0K | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | |
| Paid-in Capital | $503M | $502M | $499M | $417M | $416M | $415M | $412M | $314M | $313M | $270M | $269M | $267M | $266M | $264M | $263M | $261M | |
| Retained Earnings | $-342M | $-320M | $-302M | $-285M | $-272M | $-257M | $-245M | $-232M | $-221M | $-211M | $-200M | $-190M | $-180M | $-169M | $-160M | $-121M | |
| AOCI | $-363.0K | $-364.0K | $90.0K | $143.0K | $77.0K | $89.0K | $2.0K | $29.0K | · | $-1.0K | $-31.0K | $-165.0K | $-336.0K | $-469.0K | $-688.0K | $-1M | |
| Stockholders' Equity | $161M | $181M | $196M | $132M | $144M | $158M | $167M | $82M | $92M | $58M | $68M | $77M | $85M | $95M | $102M | $139M | |
| Liabilities + Equity | $176M | $192M | $209M | $145M | $157M | $169M | $181M | $94M | $102M | $68M | $79M | $88M | $95M | $106M | $113M | $149M | |
| Shares Outstanding | 59,083,935 | 55,055,582 | 53,587,260 | 38,587,260 | 38,581,863 | 38,577,813 | 35,044,772 | 20,629,772 | 11,364,903 | 11,433,837 | 11,364,903 | 11,364,903 | 11,307,962 | 11,306,753 | 11,267,389 | 11,267,389 |
Arus Kas 8
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $1M | $1M | $1M | $1M | $903.0K | $833.0K | $904.0K | $931.0K | $1M | $1M | $1M | $1M | $2M | $2M | $1M | $1M | |
| Operating Cash Flow | $-15M | $-21M | $-17M | $-12M | $-12M | $-15M | $-9M | $-8M | $-8M | $-10M | $-9M | $-7M | $-9M | $-13M | $-5M | $-5M | |
| CapEx | · | · | $24.0K | $4.0K | $22.0K | $44.0K | $0 | $8.0K | · | · | $0 | $37.0K | $2.0K | $6.0K | $6.0K | $83.0K | |
| Investing Cash Flow | $18M | $-15M | $-27M | $-7M | $-48M | $-58M | $22M | $-29M | $3M | $23M | $15M | $6M | $22M | $10M | $-18M | $19M | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | $76.0K | · | $27.0K | $0 | $64.0K | $0 | $18.0K | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $-76.0K | · | · | · | $-64.0K | · | · | |
| Financing Cash Flow | $-26.0K | $1M | $81M | $13.0K | $8.0K | $2M | $98M | $0 | $42M | $-76.0K | $0 | $-27.0K | $0 | $-64.0K | $0 | $-18.0K | |
| Free Cash Flow | · | · | · | · | · | $-15M | · | · | · | · | · | · | · | $-13M | · | · |
Profitabilitas 5
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1575.9% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Net Margin | -1464.0% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -1575.9% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| ROA | -13.0% | -9.9% | · | -11.1% | -11.6% | -10.1% | · | -12.3% | -9.7% | -12.7% | · | -8.3% | -9.0% | -6.8% | · | -4.7% | |
| ROE | -14.2% | -10.5% | · | -12.4% | -12.7% | -11.0% | · | -14.1% | -10.7% | -14.5% | · | -9.1% | -9.8% | -7.3% | · | -5.0% |
Likuiditas & Solvabilitas 2
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 11.0 | 15.7 | · | 13.7 | 12.8 | 18.0 | · | 9.8 | 16.3 | 10.5 | · | 11.5 | 17.1 | 14.8 | · | 26.6 | |
| Quick Ratio | 10.7 | 15.2 | · | 13.4 | 12.5 | 17.7 | · | 9.4 | 15.9 | 10.0 | · | 10.9 | 16.3 | 13.5 | · | 26.0 |
Efisiensi 1
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Valuasi (TTM) 8
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-68M | $-58M | · | $-51M | $-48M | $-44M | · | $-42M | $-42M | $-41M | · | $-38M | $-37M | $-36M | · | $-38M | |
| Market Cap | $226M | $287M | · | $168M | $117M | $164M | · | $38M | $24M | $46M | · | $19M | $27M | $35M | · | $33M | |
| P/E | -2.9 | -4.1 | · | -3.0 | -1.9 | -1.9 | · | -0.7 | -0.6 | -1.1 | · | -0.5 | -0.7 | -1.0 | · | -0.9 | |
| P/B | 1.4 | 1.6 | · | 1.3 | 0.8 | 1.0 | · | 0.5 | 0.3 | 0.8 | · | 0.2 | 0.3 | 0.4 | · | 0.2 | |
| P / Tangible Book | 1.4 | 1.6 | · | 1.3 | 0.8 | 1.0 | · | 0.5 | 0.3 | 0.8 | · | 0.2 | 0.3 | 0.4 | · | 0.3 | |
| P / Cash Flow | · | -13.4 | · | · | · | -11.2 | · | · | · | -4.4 | · | · | · | -2.7 | · | · | |
| P / FCF | · | · | · | · | · | -11.1 | · | · | · | · | · | · | · | -2.7 | · | · | |
| Earnings Yield | -34.8% | -24.2% | · | -33.3% | -52.5% | -51.9% | · | -152.5% | -158.2% | -90.8% | · | -200.6% | -135.6% | -102.2% | · | -113.5% |
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
Laporan Laba Rugi
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Laba Bersih | $-57M | $-45M | $-40M | $-66M | $-47M |
| EPS Dilusian | $-1.34 | $-2.17 | $-3.57 | $-5.86 | $-4.21 |
Neraca
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Rasio Lancar | 14.6 | 15.7 | 11.2 | 15.0 | 21.7 |
| Rasio Cepat | 14.2 | 15.5 | 10.7 | 14.7 | 21.2 |
Arus Kas
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Arus Kas Bebas | $-56M | $-36M | $-38M | $-27M | $-35M |
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
📊
Pilih metrik yang penting bagi Anda — klik ➕ di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Pemilik institusional (13F) 127 pengaju · $162.3M total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 31 (-1 vs Kuartal sebelumnya) | 17 (-4 vs Kuartal sebelumnya) | 39 (-8 vs Kuartal sebelumnya) | 33 (+10 vs Kuartal sebelumnya) | -2.2M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | $27.154.562 | 5.207.011 | 16,73% | Saham |
| MILLENNIUM MANAGEMENT LLC | $11.846.454 | 3.101.166 | 7,30% | Saham |
| Velan Capital Investment Management LP | $10.866.571 | 2.844.652 | 6,70% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $8.786.508 | 2.300.133 | 5,41% | Saham |
| Blackstone Inc. | $8.654.263 | 2.265.514 | 5,33% | Saham |
| ORBIMED ADVISORS LLC | $8.480.400 | 2.220.000 | 5,23% | Saham |
| Sio Capital Management, LLC | $7.341.551 | 1.921.872 | 4,52% | Saham |
| ACORN CAPITAL ADVISORS, LLC | $6.693.079 | 1.752.115 | 4,12% | Saham |
| Integral Health Asset Management, LLC | $5.730.000 | 1.500.000 | 3,53% | Saham |
| 5AM Venture Management, LLC | $5.232.567 | 1.369.782 | 3,22% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $4.362.540 | 1.141.710 | 2,69% | Saham |
| STATE STREET CORP | $4.080.887 | 1.068.295 | 2,51% | Saham |
| Qube Research & Technologies Ltd | $3.993.871 | 1.045.516 | 2,46% | Saham |
| Balyasny Asset Management L.P. | $3.921.960 | 1.026.691 | 2,42% | Saham |
| BAKER BROS. ADVISORS LP | $3.711.565 | 971.614 | 2,29% | Saham |
| ADAR1 Capital Management, LLC | $3.592.756 | 940.512 | 2,21% | Saham |
| CITADEL ADVISORS LLC | $3.414.045 | 893.729 | 2,10% | Saham |
| BANK OF AMERICA CORP /DE/ | $3.287.679 | 860.649 | 2,03% | Saham |
| DIMENSIONAL FUND ADVISORS LP | $2.389.918 | 625.633 | 1,47% | Saham |
| Point72 Asset Management, L.P. | $2.096.920 | 548.932 | 1,29% | Saham |
| Catalio Capital Management, LP | $1.986.965 | 520.148 | 1,22% | Saham |
| GOLDMAN SACHS GROUP INC | $1.936.106 | 506.834 | 1,19% | Saham |
| Walleye Capital LLC | $1.930.750 | 505.432 | 1,19% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.878.130 | 491.657 | 1,16% | Saham |
| MORGAN STANLEY | $1.833.917 | 480.083 | 1,13% | Saham |
| UBS Group AG | $1.723.538 | 451.188 | 1,06% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $1.278.489 | 334.683 | 0,79% | Saham |
| Verdad Advisers, LP | $1.192.791 | 312.249 | 0,73% | Saham |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $1.129.058 | 295.565 | 0,70% | Saham |
| RENAISSANCE TECHNOLOGIES LLC | $960.730 | 251.500 | 0,59% | Saham |
| OPPENHEIMER & CO INC | $910.543 | 238.362 | 0,56% | Saham |
| Jump Financial, LLC | $775.842 | 203.100 | 0,48% | Saham |
| CIBC WORLD MARKET INC. | $636.011 | 166.495 | 0,39% | Saham |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $603.449 | 157.971 | 0,37% | Saham |
| J. Goldman & Co LP | $515.700 | 135.000 | 0,32% | Saham |
| SUPERSTRING CAPITAL MANAGEMENT LP | $463.966 | 121.457 | 0,29% | Saham |
| Fisher Asset Management, LLC | $380.342 | 99.566 | 0,23% | Saham |
| AMERICAN CENTURY COMPANIES INC | $376.220 | 98.487 | 0,23% | Saham |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $325.961 | 85.330 | 0,20% | Saham |
| TWO SIGMA INVESTMENTS, LP | $266.071 | 69.652 | 0,16% | Saham |
| FMR LLC | $260.012 | 68.066 | 0,16% | Saham |
| XTX Topco Ltd | $244.281 | 63.948 | 0,15% | Saham |
| RHUMBLINE ADVISERS | $241.589 | 63.245 | 0,15% | Saham |
| TRUIST FINANCIAL CORP | $229.200 | 60.000 | 0,14% | Saham |
| Assenagon Asset Management S.A. | $229.024 | 59.954 | 0,14% | Saham |
| Trexquant Investment LP | $227.733 | 59.616 | 0,14% | Saham |
| DEUTSCHE BANK AG\ | $220.464 | 57.713 | 0,14% | Saham |
| ALPS ADVISORS INC | $217.897 | 57.041 | 0,13% | Saham |
| AMERIPRISE FINANCIAL INC | $214.863 | 56.247 | 0,13% | Saham |
| PRUDENTIAL FINANCIAL INC | $193.789 | 50.730 | 0,12% | Saham |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | $191.000 | 50.000 | 0,12% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $154.252 | 40.380 | 0,10% | Saham |
| Alyeska Investment Group, L.P. | $151.753 | 39.726 | 0,09% | Saham |
| Quadrature Capital Ltd | $150.199 | 39.319 | 0,09% | Saham |
| Marex Group Ltd | $134.655 | 35.250 | 0,08% | Saham |
| WINTON GROUP Ltd | $125.296 | 32.800 | 0,08% | Saham |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | $113.454 | 29.700 | 0,07% | Saham |
| MetLife Investment Management, LLC | $108.404 | 28.378 | 0,07% | Saham |
| MARSHALL WACE, LLP | $106.995 | 28.009 | 0,07% | Saham |
| ALLIANCEBERNSTEIN L.P. | $93.988 | 18.040 | 0,06% | Saham |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $92.043 | 24.095 | 0,06% | Saham |
| WOLVERINE TRADING, LLC | $88.200 | 20.000 | 0,05% | Opsi jual |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $87.478 | 22.900 | 0,05% | Opsi jual |
| CITIGROUP INC | $80.698 | 21.125 | 0,05% | Saham |
| Jain Global LLC | $80.220 | 21.000 | 0,05% | Saham |
| Invesco Ltd. | $78.295 | 20.496 | 0,05% | Saham |
| Vanguard Global Advisers, LLC | $76.885 | 20.127 | 0,05% | Saham |
| PRELUDE CAPITAL MANAGEMENT, LLC | $74.922 | 19.613 | 0,05% | Saham |
| EntryPoint Capital, LLC | $73.673 | 19.286 | 0,05% | Saham |
| LPL Financial LLC | $73.077 | 19.130 | 0,05% | Saham |
| VANGUARD GROUP INC | $70.479 | 13.223 | 0,04% | Saham |
| Squarepoint Ops LLC | $69.234 | 18.124 | 0,04% | Saham |
| IEQ CAPITAL, LLC | $68.489 | 17.929 | 0,04% | Saham |
| Police & Firemen's Retirement System of New Jersey | $67.114 | 17.569 | 0,04% | Saham |
| BARCLAYS PLC | $60.665 | 15.881 | 0,04% | Saham |
| BlackRock, Inc. | $58.950 | 15.432 | 0,04% | Saham |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $56.834 | 14.878 | 0,04% | Saham |
| INTECH INVESTMENT MANAGEMENT LLC | $51.807 | 13.562 | 0,03% | Saham |
| WOLVERINE TRADING, LLC | $51.315 | 11.636 | 0,03% | Saham |
| Mariner, LLC | $45.441 | 11.899 | 0,03% | Saham |
| Bank of New York Mellon Corp | $43.877 | 11.486 | 0,03% | Saham |
| VOYA INVESTMENT MANAGEMENT LLC | $43.812 | 11.469 | 0,03% | Saham |
| D. E. Shaw & Co., Inc. | $42.452 | 11.113 | 0,03% | Saham |
| COMMONWEALTH EQUITY SERVICES, LLC | $42.020 | 11.000 | 0,03% | Saham |
| WELLS FARGO & COMPANY/MN | $41.161 | 10.775 | 0,03% | Saham |
| Essential Partners LLC | $37.444 | 9.802 | 0,02% | Saham |
| MERCER GLOBAL ADVISORS INC /ADV | $34.525 | 9.038 | 0,02% | Saham |
| NORTHERN TRUST CORP | $32.061 | 8.393 | 0,02% | Saham |
| CWM, LLC | $30.458 | 5.846 | 0,02% | Saham |
| NEW YORK STATE COMMON RETIREMENT FUND | $30.178 | 7.900 | 0,02% | Saham |
| BNP PARIBAS FINANCIAL MARKETS | $28.788 | 7.536 | 0,02% | Saham |
| Tower Research Capital LLC (TRC) | $19.062 | 4.990 | 0,01% | Saham |
| Legal & General Group Plc | $17.129 | 4.490 | 0,01% | Saham |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $14.645 | 2.811 | 0,01% | Saham |
| Ameritas Investment Partners, Inc. | $12.598 | 3.298 | 0,01% | Saham |
| Nuveen, LLC | $9.642 | 2.524 | 0,01% | Saham |
| Integrated Wealth Concepts LLC | $6.684 | 1.750 | 0,00% | Saham |
| Arax Advisory Partners | $6.383 | 1.671 | 0,00% | Saham |
| Russell Investments Group, Ltd. | $6.085 | 1.593 | 0,00% | Saham |
| ROYAL BANK OF CANADA | $6.000 | 1.577 | 0,00% | Saham |
Orang dalam perusahaan 40 orang dalam · 16 pejabat · 20 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Jesse Shefferman | CEO and President | 29 Juni 2026 M | 691.832 | 0 | 1 | $-882.160 |
| Timothy P Noyes | President and CEO | 31 Jan. 2019 A | 0 | 0 | 0 | $0 |
| Patrick Fabbio | Chief Financial Officer | 26 Jan. 2026 F | 64.115 | 0 | 0 | $0 |
| Blaine Davis | Chief Financial Officer | 15 Juli 2022 F | 20.662 | 0 | 0 | $0 |
| George Arthur Eldridge, | Sr VP, CFO, Treasr, Asst Secy | 18 Jan. 2019 A | 29.132 | 0 | 0 | $0 |
| William Conkling | Chief Commercial Officer | 2 Juni 2026 F | 69.992 | 0 | 0 | $0 |
| Jacqueline Zummo | Chief R&D Officer | 8 April 2026 S | 94.827 | 0 | 2 | $-124.989 |
| Hannah Fry | VP, Controller | 26 Jan. 2026 F | 42.723 | 0 | 0 | $0 |
| Leonardo Viana Nicacio | Chief Medical Officer | 16 Jan. 2026 A | 78.181 | 0 | 0 | $0 |
| Jathin Bandari | Chief Medical Officer | 19 Jan. 2024 A | 56.704 | 0 | 0 | $0 |
| Julio Casoy | Chief Medical Officer | 9 Jan. 2020 A | 45.500 | 0 | 0 | $0 |
| Steven Keith Burke | SVP and Chief Medical Officer | 15 Maret 2019 G | 26.332 | 0 | 0 | $0 |
| Bradley J Hartman | VP, People | 18 Jan. 2019 A | — | 0 | 0 | $0 |
| Matthew Paul Kowalsky | VP, Legal and Secretary | 18 Jan. 2019 A | 29.479 | 0 | 0 | $0 |
| Scott E. Toner | Senior VP of Commercial | 18 Jan. 2019 A | 23.357 | 0 | 0 | $0 |
| Gottlieb Daniel Philip | VP Corporate Development | 18 Jan. 2019 A | 244 | 0 | 0 | $0 |
| Michael Edward Solomon | Direktur | 15 Juni 2026 A | 26.500 | 0 | 0 | $0 |
| Jane Huang | Direktur | 15 Juni 2026 A | — | 0 | 0 | $0 |
| Barry P Flannelly | Direktur | 15 Juni 2026 A | — | 0 | 0 | $0 |
| Cynthia Smith | Direktur | 15 Juni 2026 A | — | 0 | 0 | $0 |
| Richard S Levy | Direktur | 15 Juni 2026 A | 51.000 | 0 | 0 | $0 |
| Roger Garceau | Direktur | 15 Juni 2026 A | 33.000 | 0 | 0 | $0 |
| Gregory Sargen | Direktur | 15 Juni 2026 A | 31.000 | 0 | 0 | $0 |
| Luke M Beshar | Direktur | 15 Juni 2026 A | 198.000 | 0 | 0 | $0 |
| Scott Braunstein | Direktur | 9 Juni 2020 A | 26.500 | 0 | 0 | $0 |
| John Gordon Freund | Direktur | 8 Nov. 2019 C | 2.175.882 | 0 | 0 | $0 |
| Hubert Birner | Direktur | 8 Juni 2018 A | 1.943.059 | 0 | 0 | $0 |
| Paul J Hastings | Direktur | 8 Juni 2018 A | — | 0 | 0 | $0 |
| Scott A Canute | Direktur | 8 Juni 2018 A | — | 0 | 0 | $0 |
| Garen G Bohlin | Direktur | 8 Juni 2018 A | 53.312 | 0 | 0 | $0 |
| Jonathan S Leff | Direktur | 8 Juni 2018 A | — | 0 | 0 | $0 |
| Brendan O'Leary | Direktur | 9 Juni 2016 A | 1.387.198 | 0 | 0 | $0 |
| Dmitry Kobyzev | Direktur | 2 Juni 2015 A | 1.165.344 | 0 | 0 | $0 |
| Gregory D Phelps | Direktur | 2 Juni 2015 A | — | 0 | 0 | $0 |
| Opaleye, L.P. | Pemilik 10% | 9 Jan. 2020 A | 2.208.472 | 0 | 0 | $0 |
| Martin Sebastian Olivo | — | 10 Juni 2021 P | 14.344 | 0 | 0 | $0 |
| Randall Marshall | — | 14 Sep. 2020 S | 585.600 | 0 | 0 | $0 |
| Timothy Haines | — | 12 Nov. 2019 C | 2.144.517 | 0 | 0 | $0 |
| Abingworth LLP | — | 12 Nov. 2019 C | 2.144.517 | 0 | 0 | $0 |
| Stuart A Kingsley | — | 8 Juni 2018 A | — | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Aktivis & pemilik 5%+ 8 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| Deerfield Partners, L.P., Deerfield Private Design Fund III, L.P., Deerfield Private Design Fund IV, L.P., Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Management Company, L.P., James E. Flynn | 8 Jan. 2021 | — | Pengajuan awal | — | SEC |
| Opaleye Management Inc., Opaleye, L.P., James Silverman ×3 pengajuan | 25 Sep. 2020 | — | Pengajuan awal | — | SEC |
| Deerfield Special Situations Fund, L.P., Deerfield Partners, L.P., Deerfield Private Design Fund III, L.P., Deerfield Private Design Fund IV, L.P., Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Management Company, L.P., James E. Flynn ×6 pengajuan | 17 Jan. 2020 | — | Pengajuan awal | — | SEC |
| Abingworth LLP, Abingworth Bioventures VI, LP | 17 Jan. 2020 | — | Pengajuan awal | M&A / penjualan | SEC |
| Abingworth LLP 98-051-8585, Abingworth Bioventures VI, LP 98-040-3543 ×3 pengajuan | 14 Nov. 2019 | — | Pengajuan awal | Kampanye dewan | SEC |
| TVM Life Science Ventures VI L.P., TVM Life Science Ventures VI GmbH & Co. KG, TVM Life Science Ventures Management VI L.P., Hubert Birner, Stefan Fischer, Helmut Schuehsler ×2 pengajuan | 2 Agu 2017 | — | Pengajuan awal | Investasi pasif | SEC |
| Deerfield Mgmt, L.P., Deerfield Management Company, L.P., Deerfield Mgmt III, L.P., Deerfield Special Situations Fund, L.P., Deerfield Partners, L.P., Deerfield International Master Fund, L.P., Deerfield Private Design Fund III, L.P., James E. Flynn | 29 Juni 2017 | — | Pengajuan awal | Investasi pasif | SEC |
| Skyline Venture Partners Qualified Purchaser Fund IV, L.P., Skyline Venture Management IV, LLC, John G. Freund, Yasunori Kaneko | 3 Nov. 2014 | — | Pengajuan awal | Investasi pasif | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Kepemilikan ETF Dimiliki oleh 22 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| SBIO · ALPS ETF Trust | 0,16% | 55.748 NS | 31 Mei 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,02% | 91.844 NS | 31 Mei 2026 | N-PORT |
| RSSL · Global X Funds | 0,01% | 22.265 NS | 30 April 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,01% | 179.929 NS | 30 April 2026 | N-PORT |
| ITWO · ProShares Trust | 0,01% | 2.419 NS | 31 Mei 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,01% | 3.715 NS | 30 April 2026 | N-PORT |
| UWM · ProShares Trust | 0,00% | 1.891 NS | 31 Mei 2026 | N-PORT |
| URTY · ProShares Trust | 0,00% | 1.912 NS | 31 Mei 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 48 NS | 31 Mei 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 5.791 NS | 30 April 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 18.477 NS | 30 April 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 7.914 NS | 30 April 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 20.174 NS | 30 April 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 15 Juli 2026 | Harian |
| VTI · VANGUARD INDEX FUNDS | — | — | 15 Juli 2026 | Harian |
| VFMO · VANGUARD WELLINGTON FUND | — | — | 30 Juli 2026 | Harian |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 15 Juli 2026 | Harian |
| VTWV · VANGUARD SCOTTSDALE FUNDS | — | — | 15 Juli 2026 | Harian |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 15 Juli 2026 | Harian |
| IWN · iShares Trust | — | — | 17 Agu 2026 | Harian |
| IWM · iShares Trust | — | — | 18 Agu 2026 | Harian |
| IWC · iShares Trust | — | — | 18 Agu 2026 | Harian |